3x EBITDA multiple when the average is 4x for acquisitions since IPO. They already exceeded their $20m annual spend so there was no need to acquire these so it looks more like an opportunistic purchase with a very low entry price. I live one suburb over from Abbotsford. It's massive Asian population area where everyone wears glasses. I'd suspect audiology will be added at some point to the clinics for additional revenue stream.
HLA Price at posting:
$1.76 Sentiment: Hold Disclosure: Held
